Nevolat Weight Loss Injections: What the Search Results Aren't Telling You

Step 1: Understand what is actually licensed for weight management in the UK

Two injectable medicines currently hold MHRA authorisation for weight management in UK adults. The first is tirzepatide, sold under the brand name Mounjaro by Eli Lilly. It works on two gut-hormone receptors simultaneously (GIP and GLP-1) reducing appetite and slowing how quickly the stomach empties. The second is semaglutide, sold as Wegovy by Novo Nordisk, which targets the GLP-1 receptor alone. Both are given as once-weekly subcutaneous injections using pre-filled pens.

Tirzepatide comes in six strengths, starting at 2.5mg. That opening dose exists to let your body adjust, nausea is much less common when the medicine is introduced gently. The prescriber then steps the dose upward, typically every four weeks, based on how you're tolerating it. Wegovy follows a similar graduated approach, starting at 0.25mg and working toward a maintenance dose, with the MHRA having approved a higher 7.2mg option in January 2026. You can read a broader overview of how weight-loss injections are used in the UK to see how both medicines fit into a structured treatment plan.

Neither medicine is a shortcut, and neither is available without a clinical assessment. If a product called Nevolat (or anything else with an unfamiliar name) is being offered as an equivalent, there is no regulatory basis for that claim. The MHRA publishes a searchable product register; if a name does not appear there as an authorised medicine, it is not authorised.

Step 2: Recognise the red flags for unlicensed and counterfeit products

The MHRA has been explicit: counterfeit weight-loss pens are in circulation in the UK, some sold through social media accounts and informal online marketplaces. In October 2025, enforcement teams raided the first illicit UK site manufacturing fake tirzepatide pens. Earlier operations seized roughly 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million. Some of those counterfeit pens were found to contain insulin rather than the stated medicine, a potentially life-threatening substitution. The MHRA's Yellow Card scheme accepts reports of suspect medicines and sellers, and the regulator actively encourages the public to use it.

Specific red flags include: sellers offering injectable weight-loss products without requiring a prescription or clinical questionnaire; pricing significantly below current private market rates; brand names that do not appear on the MHRA or eMC register; and products promoted through social media DMs or informal group chats. Nevolat fits this pattern precisely. There is no prescribing pathway for it, no approved patient information leaflet and no clinical trial evidence behind it. That combination should be reason enough to step back.

The one practical check that takes less than a minute: go to the GPhC pharmacy register and search the name or registration number of any pharmacy you're considering. Legitimate online pharmacies are listed there. If a seller isn't, they cannot lawfully supply prescription medicines to you in the UK.

Step 3: Know who qualifies for the medicines that are actually licensed

Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or a BMI of 27 or above where at least one weight-related condition is present, things like type 2 diabetes, high blood pressure, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. What weight qualifies you for these injections is a common question, and the honest answer is that the BMI figure is a starting point, not a guarantee, a prescriber assesses the whole picture, including your medical history and current medicines.

Neither medicine is recommended during pregnancy, while breastfeeding or if you're actively trying to conceive. They are not licensed for under-18s. If you have a history of pancreatitis or certain gastrointestinal conditions, your prescriber will need to weigh that up with you. The NHS tirzepatide patient information at nhs.uk/medicines/tirzepatide sets out the full contraindication list in plain language.

On cost: private treatment prices vary by provider and dose, and it is worth reading what weight-loss injections actually cost in the UK before comparing options. The NHS does offer both medicines through specific routes, though criteria are strict and waiting lists for Wegovy in particular can be long. Some GP practices began prescribing tirzepatide under the 2026/27 contract, whether your GP can prescribe a weight-loss injection depends on the practice and your area.

Step 4: Access a licensed medicine through a regulated UK pharmacy

The lawful route to either injection in the UK is straightforward in principle: complete a clinical consultation, have a GPhC-registered prescriber review your answers, and receive a prescription if you are suitable. At nume, that consultation is free, reviewed the same day by a named prescriber (a real clinician reads your responses, not a piece of software) and, if approved, treatment is dispatched the same day for free next-working-day delivery. If you are based on the Wirral, you can find out more about accessing weight loss injections in the Wirral area before deciding how to proceed. You can explore the full range of weight-loss treatments available through nume and start your consultation there if you'd like a clinician to assess whether you're a candidate for one of the licensed medicines.

The broader picture on medical weight management in the UK is evolving quickly, with new formulations and NHS rollout phases arriving regularly. Sticking to MHRA-authorised medicines, supplied by a pharmacy you can verify, is the one fixed point in all of that. Anything sold outside that framework (Nevolat included) carries risks that no claimed discount or convenient delivery can offset.